Drug Type Synthetic peptide |
Synonyms Ambamustine |
Target |
Mechanism DNA inhibitors(DNA inhibitors), DNA alkylating agents |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC29H40Cl3FN4O4S |
InChIKeyLPRJQYQONDUPFK-OUKLVGRUSA-N |
CAS Registry83996-50-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neoplasms | IT | - | |
Neoplasms | IT | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Phase 3 | IT | - | |
Small Cell Lung Cancer | Phase 3 | IT | - | |
Neoplasms | Discovery | US | - |